U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 12b-25
Commission File Number 2-89616
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR
For Period Ended: September 30, 1998
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
Part I-Registrant Information
Full Name of Registrant: CONSOLIDATED MEDICAL MANAGEMENT, INC.
Former Name if Applicable: N/A
Address of principal executive office (Street and number): 13005 JUSTICE
AVENUE
City, State and Zip Code: BATON ROUGE, LA 70816 8598
Part II-Rules 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
[X] a.The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
[X] b.The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be
filed on or before the fifteenth calendar day following the prescribed due
date; or the subject quarterly report or transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth calendar day following
the prescribed due date; and
[ ] c.The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III-Narrative
State below in reasonable detail the reasons why the form 10-K, 11-K,
20-F, 10-Q or N-SAR, or the transition report or portion thereof could not be
filed within the prescribed time period. (Attach extra sheets of needed.)
The Company has been engaged in a number of acquisitions during the
recent months and has been unable to provide the Company's accountant with all
of the accounting information necessary to complete the quarterly report.
Part IV-Other Information
1.Name and telephone number of person to contact in regard to this
notification
Sunni M. Wooley 504292-3100
(Name) (Area Code) (Telephone No.)
2.Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is
no, identify report(s).
[X] Yes [ ] No
3.Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion
thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results can not be made.
CONSOLIDATED MEDICAL MANAGEMENT, INC.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: November 16, 1998 By /s/ Sunni M. Wooley, President
PART IV, Item 3.
The Company had no operations or revenues for the quarter ended September 30,
1997, and had a net loss of ($4,914) for legal fees and office expenses. In
May 1998 the Company acquired an operating subsidiary, Consolidated Medical
Management, Inc., a Louisiana corporation, and subsequently acquired another
business and assets used in an operating company. For the quarter ended
September 30, 1998, the Company, on a consolidated basis, had revenues from
operations of $282,832, total operating expenses of $478,218, and a net loss
of ($444,013). The Company is still compiling the pro forma information for
the acquired subsidiary for the quarter ended September 30, 1997.
